Impact of Aprepitant on Emesis Control, Dose Intensity, and Recurrence-Free Survival in a Population-Based Cohort of Head and Neck Cancer Patients Receiving High-Dose Cisplatin Chemotherapy

Journal of Community and Supportive Oncology - United States

doi 10.12788/jcso.0085